AXS-05 (dextromethorphan-bupropion)
AXS-05-TRD-202
Phase 2 small_molecule terminated
Quick answer
AXS-05 (dextromethorphan-bupropion) for Treatment Resistant Depression is a Phase 2 program (small_molecule) at Axsome Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Axsome Therapeutics
- Indication
- Treatment Resistant Depression
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated